HANNARİCİ, Z. Et Al. 2022. Reply to John L. Frater's letter to the editor: Use of laboratory hematology data in melanoma research: comments on 'A novel prognostic biomarker for cutaneous malignant melanoma: red cell distribution width (RDW) to lymphocyte ratio'. MELANOMA RESEARCH , vol.32, no.4 , 302.

HANNARİCİ, Z., YILMAZ, A., Buyukbayram, M. E., Tekin, S. B., & BİLİCİ, M., (2022). Reply to John L. Frater's letter to the editor: Use of laboratory hematology data in melanoma research: comments on 'A novel prognostic biomarker for cutaneous malignant melanoma: red cell distribution width (RDW) to lymphocyte ratio'. MELANOMA RESEARCH , vol.32, no.4, 302.

HANNARİCİ, Zekeriya Et Al. "Reply to John L. Frater's letter to the editor: Use of laboratory hematology data in melanoma research: comments on 'A novel prognostic biomarker for cutaneous malignant melanoma: red cell distribution width (RDW) to lymphocyte ratio'," MELANOMA RESEARCH , vol.32, no.4, 302, 2022

HANNARİCİ, Zekeriya Et Al. "Reply to John L. Frater's letter to the editor: Use of laboratory hematology data in melanoma research: comments on 'A novel prognostic biomarker for cutaneous malignant melanoma: red cell distribution width (RDW) to lymphocyte ratio'." MELANOMA RESEARCH , vol.32, no.4, pp.302, 2022

HANNARİCİ, Z. Et Al. (2022) . "Reply to John L. Frater's letter to the editor: Use of laboratory hematology data in melanoma research: comments on 'A novel prognostic biomarker for cutaneous malignant melanoma: red cell distribution width (RDW) to lymphocyte ratio'." MELANOMA RESEARCH , vol.32, no.4, p.302.

@article{article, author={Zekeriya HANNARİCİ Et Al. }, title={Reply to John L. Frater's letter to the editor: Use of laboratory hematology data in melanoma research: comments on 'A novel prognostic biomarker for cutaneous malignant melanoma: red cell distribution width (RDW) to lymphocyte ratio'}, journal={MELANOMA RESEARCH}, year=2022, pages={302} }